文献速递消化道肿瘤与早癌消化内镜

人工智能辅助II期结直肠癌风险分层:语义增强深度学习多机构验证

Artificial Intelligence-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically Enhanced Deep Learning.
PubMed 文献 · Gastroenterology · 2026-07-28

本研究开发并验证了语义增强多实例学习模型SÉMIL,基于1608张H&E全切片图像来自3个队列(Austin n=697,MCO n=478,DYNAMIC n=433),用于自动评估浸润前沿以改善II期结直肠癌预后分层。SÉMIL在二元分类上优于非语义多实例学习,并在内部和外部验证队列中均展示出预后分层能力,包括在NCCN定义的高危II期患者中成功分层。

要点

  • SÉMIL在II期结直肠癌中实现可重复的预后分层,高危组风险比达2.10-4.73。

核心结论

  • SÉMIL在II期结直肠癌中验证了预后分层能力,可能有助于细化NCCN高危类别内的风险评估。

研究设计与样本

  • 开发并验证语义增强多实例学习(SÉMIL),整合视觉-语言基础模型与注意力多实例学习,从H&E全切片图像自动评估浸润性。
  • 在来自3个队列的1608张H&E全切片图像上训练和验证(Austin n=697,MCO n=478,DYNAMIC n=433)。

主要发现

  • 二元分类中,SÉMIL在所有队列中优于非语义多实例学习(外部验证:AUC 0.713-0.821 vs 0.686-0.803)。

临床怎么用

  • SÉMIL可用于II期结直肠癌的自动化浸润前沿评估,辅助识别高危患者以指导辅助化疗决策。
  • 在NCCN高危II期患者中,SÉMIL可进一步细化风险分层,帮助识别治疗决策最具挑战性的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Accurate risk stratification in Stage II colorectal cancer is essential for treatment decision-making, as current guidelines recommend adjuvant chemotherapy only for patients with a high risk of relapse. We aimed to develop and validate an artificial intelligence-based approach for automated invasive front assessment to improve prognostic stratification in this population. METHODS: We developed Semantically-Enhanced Multiple Instance Learning (SÉMIL), integrating vision-language foundation models with attention-based multiple instance learning for automated invasiveness assessment from H&E-stained whole slide images. We trained and validated SÉMIL on 1608 H&E-stained whole slide images from 3 cohorts (Austin n = 697, MCO n = 478, DYNAMIC n = 433). We compared SÉMIL performance against manual pathologist assessment and nonsemantic MIL approaches. RESULTS: For binary classification, SÉMIL outperformed nonsemantic MIL across all cohorts (external validation: AUC 0.713-0.821 vs 0.686-0.803). For survival prediction, SÉMIL demonstrated validated prognostic stratification in both the internal (Austin: hazard ratio [HR] = 4.73; P = .0012) and the 2 external (MCO: HR = 2.84; P = .0032; DYNAMIC: HR = 2.10; P = .0396) Stage II validation cohorts. Critically, among National Comprehensive Cancer Network guideline-defined high-risk Stage II patients, SÉMIL successfully stratified outcomes across all 3 cohorts (HRs, 2.96-3.50; all P < .05), demonstrating consistent reproducible performance. In multivariate analysis of the combined Stage II cohort (n = 1220), SÉMIL retained independent prognostic significance (HR = 1.98; P = .005) after adjusting for conventional clinicopathologic features including T stage, MMR status, and lymph node examination adequacy. Concordance analysis between SÉMIL and manual assessment showed concordant infiltrative classification identified the highest-risk group (HR = 3.96; P < .0001), with discordant cases showing intermediate risk. CONCLUSIONS: SÉMIL demonstrates validated prognostic stratification in Stage II colorectal cancer, with potential utility for refining risk assessment within National Comprehensive Cancer Network guideline-defined high-risk categories where treatment decisions are most challenging.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Magisson F, He Z, Millward J, et al. Artificial Intelligence-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically Enhanced Deep Learning. Gastroenterology. 2026. PMID: 42521098. doi:10.1053/j.gastro.2026.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。